Value assessment of deprescribing interventions: Suggestions for improvement.
作者信息
Hung Anna, Wang Jinjiao, Moriarty Frank, Manja Veena, Eshetie Tesfahun, Tegegn Henok Getachew, Anderson Timothy S, Radomski Thomas R, Steinman Michael A
机构信息
Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina, USA.
Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
出版信息
J Am Geriatr Soc. 2023 Jun;71(6):2023-2027. doi: 10.1111/jgs.18298. Epub 2023 Feb 21.
Abstract
摘要
相似文献
1
Value assessment of deprescribing interventions: Suggestions for improvement.减药干预措施的价值评估：改进建议。
J Am Geriatr Soc. 2023 Jun;71(6):2023-2027. doi: 10.1111/jgs.18298. Epub 2023 Feb 21.
2
Inappropriate polypharmacy management versus deprescribing: A review on their relationship.不适当的多种药物治疗管理与药物减量：对其关系的综述。
Basic Clin Pharmacol Toxicol. 2024 Jan;134(1):6-14. doi: 10.1111/bcpt.13920. Epub 2023 Jul 11.
3
Thoughtful Prescribing and Deprescribing.审慎处方与撤方。
Med Clin North Am. 2020 Sep;104(5):751-765. doi: 10.1016/j.mcna.2020.06.001.
4
Polypharmacy and deprescribing: just ask the patient.多重用药与减药：问问患者就知道了。
Drug Ther Bull. 2020 Jan;58(1):2. doi: 10.1136/dtb.2019.000083. Epub 2019 Nov 14.
5
Polypharmacy and Deprescribing.多重用药与减药
JAMA. 2023 Aug 15;330(7):672. doi: 10.1001/jama.2023.8872.
6
The Role of Patient Preferences in Deprescribing.患者偏好因素在减药中的作用。
Clin Geriatr Med. 2017 May;33(2):165-175. doi: 10.1016/j.cger.2017.01.004. Epub 2017 Feb 23.
7
Considering Value in Prescribing and Deprescribing for Older Adults.考虑老年人用药处方与减药的价值。
JAMA Netw Open. 2022 Feb 1;5(2):e2148606. doi: 10.1001/jamanetworkopen.2021.48606.
8
The value of deprescribing in older adults with dementia: a narrative review.老年痴呆症患者药物减量的价值：叙事性综述。
Expert Rev Clin Pharmacol. 2021 Nov;14(11):1367-1382. doi: 10.1080/17512433.2021.1961576. Epub 2021 Aug 19.
9
Building an Evidence Base for Deprescribing in the Setting of Polypharmacy.建立多重用药背景下减药的证据基础。
JAMA Netw Open. 2024 Jul 1;7(7):e2423529. doi: 10.1001/jamanetworkopen.2024.23529.
10
Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.使用减药实践和老年人潜在不适当处方标准筛选工具，以减少老年人的伤害和可预防的药物不良事件。
J Patient Saf. 2020 Sep;16(3S Suppl 1):S23-S35. doi: 10.1097/PTS.0000000000000747.
引用本文的文献
1
The U.S. deprescribing research network: Catalyzing research and action to optimize medication use in older adults.美国减药研究网络：推动优化老年人用药的研究与行动。
J Am Geriatr Soc. 2024 May;72(5):1611-1613. doi: 10.1111/jgs.18856. Epub 2024 Mar 8.
本文引用的文献
1
An external pilot cluster randomised controlled trial of a theory-based intervention to improve appropriate polypharmacy in older people in primary care (PolyPrime).一项基于理论的干预措施的外部试点整群随机对照试验，旨在改善初级保健中老年人的合理联合用药（PolyPrime）。
Pilot Feasibility Stud. 2022 Sep 10;8(1):203. doi: 10.1186/s40814-022-01161-6.
2
Recommendations for outcome measurement for deprescribing intervention studies.药物减量干预研究结局指标的推荐意见。
J Am Geriatr Soc. 2022 Sep;70(9):2487-2497. doi: 10.1111/jgs.17894. Epub 2022 Jun 1.
3
Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial.降压药物停药的成本效益：来自 OPTiMISE 试验数据的马克夫模型研究。
Hypertension. 2022 May;79(5):1122-1131. doi: 10.1161/HYPERTENSIONAHA.121.18726. Epub 2022 Mar 10.
4
Attitudes toward deprescribing among older adults with dementia in the United States.美国老年痴呆症患者对减药的态度。
J Am Geriatr Soc. 2022 Jun;70(6):1764-1773. doi: 10.1111/jgs.17730. Epub 2022 Mar 10.
5
Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations.社区居住的老年人药物减量干预措施：系统评价经济评估。
Pharmacoeconomics. 2022 Mar;40(3):269-295. doi: 10.1007/s40273-021-01120-8. Epub 2021 Dec 16.
6
Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.心力衰竭伴射血分数保留与药物超适应证联用的相关性研究。
Circ Heart Fail. 2021 Nov;14(11):e008293. doi: 10.1161/CIRCHEARTFAILURE.120.008293. Epub 2021 Oct 22.
7
Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016.2009 年至 2016 年美国医生办公室就诊的老年患者多药治疗的流行情况。
PLoS One. 2021 Aug 3;16(8):e0255642. doi: 10.1371/journal.pone.0255642. eCollection 2021.
8
A systematic review of the evidence for deprescribing interventions among older people living with frailty.衰弱老年人药物重整干预措施的证据的系统评价。
BMC Geriatr. 2021 Apr 17;21(1):258. doi: 10.1186/s12877-021-02208-8.
9
Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models.老年人潜在不适当处方和相关不良事件的经济影响：使用马尔可夫模型的成本效用分析。
BMJ Open. 2019 Jan 30;9(1):e021832. doi: 10.1136/bmjopen-2018-021832.
10
Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States.评估美国老年医疗保险受益人群对药物减量的态度。
JAMA Intern Med. 2018 Dec 1;178(12):1673-1680. doi: 10.1001/jamainternmed.2018.4720.
Zotero 插件